Quarter Financials
Galectin Therapeutics Inc. (GALT)
$1.8895
-0.03 (-1.59%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -9 | -12 | -30 | -9 | -10 | -10 | -7 | -9 |
|---|
| Dividend Paid | - | -0 | -0 | - | -0 | -0 | -0 | - |
|---|
| Retained Earnings | -330 | -321 | -310 | -299 | -290 | -281 | -271 | -263 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | - | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|